Long-term postmenopausal hormone use, obesity, and fat distribution in older women
Article Abstract:
Hormone therapy in postmenopausal women does not appear to be associated with weight gain or obesity, though women who use such therapy tend to be less obese initially. Researchers interviewed and analyzed height, weight, fat distribution, and body composition in 671 postmenopausal women. The women were evaluated at an initial visit and a follow-up visit 15 years later. Of the women, 194 never used hormone therapy, 331 used it intermittently, and 146 used it continuously between visits. The most common hormone taken was estrogen, though progestin was also taken. At the initial visit, women who continuously received hormones were significantly less obese, after adjustment for age. At follow-up, there were no significant differences between the groups in obesity, fat distribution, or body composition after adjustment for age and initial obesity. Differences were also insignificant with adjustment for tobacco and alcohol consumption, exercise, health behavior, and characteristics of menopause.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Of designer drugs, magic bullets, and gold standards
Article Abstract:
It may be premature to prescribe the drug raloxifene for postmenopausal women. This drug is similar to estrogen but does not adversely affect the breast or endometrium. A 1998 study found that raloxifene reduced LDL, or 'bad' cholesterol as much as hormone therapy with estrogen and progestin but did not raise HDL, or 'good' cholesterol as much. It has not been convincingly shown that estrogen replacement therapy reduces mortality rates from heart disease and there is even less data on raloxifene and a similar drug, tamoxifen.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
Article Abstract:
Hormone replacement therapy may reduce the risk of dementia, according to researchers who analyzed 29 studies on the subject. However, many of the studies were not well-designed so further research may be needed on this topic.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Hormones to prevent coronary disease in women: when are observational studies adequate evidence?
- Abstracts: The central role of obesity (hyperinsulinemia) in the pathogenesis of polycystic ovary syndrome. Role of androgens in the growth of endometrial carcinoma: an in vivo animal model
- Abstracts: Early neonatal mortality and cesarean delivery in Mexico City. Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies
- Abstracts: Ostrich fern poisoning - New York and western Canada, 1994. Amanita phalloides mushroom poisoning - Northern California, January 1997
- Abstracts: Empirical Evidence of Design-Related Bias in Studies of Diagnostic Tests. Magnetic Resonance Angiography for the Evaluation of Lower Extremity Arterial Disease: A Meta-analysis